Copper and zinc are both essential trace elements and are required for the proper function of many important metalloenzymes. The uptake of both copper and zinc requires specific, but different, carriers in the intestine. Copper excretion takes place only in the liver, and its homeostasis is tightly controlled, as copper can be highly toxic. The balance between uptake and excretion of copper is disturbed in Wilson disease and Menkes disease, as well as in two milder variants of Menkes disease: the occipital horn syndrome and X-linked distal hereditary neuropathy. Both Wilson and Menkes diseases have specific pathophysiological manifestations, which are for Wilson disease mainly related to copper accumulation in the liver and brain and for Menkes disease to a systemic shortage of copper, resulting in an insufficient function of copper-containing enzymes, such as tyrosinase, lysyl oxidase and dopamine-beta hydroxylase. The absence of another copper-containing enzyme, ceruloplasmin, which is due to mutations in the corresponding gene, will result in iron overload in the liver, brain and pancreas, pointing to the role of this serum protein in iron metabolism. It is further discussed in the chapter on iron metabolism.
Zinc is a cofactor for over 100 enzymes and, as such, is involved in all major metabolic pathways. It is essential for nucleic acid metabolism and protein synthesis and its regulation through the so-called zinc-finger proteins. Zinc deficiency, either hereditary or acquired, therefore has major detrimental effects. Conversely, high serum zinc has few, probably because of its binding to albumin and α2-macroglobulin. Acrodermatitis enteropathica, the main inborn error of zinc metabolism, is due to mutations in the intestinal carrier for zinc and will result in periorificial and acral dermatitis, diarrhoea, infections and growth retardation.
Serum Copper Wilson Disease Zinc Transport Menkes Disease Acrodermatitis Enteropathica
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.
de Bie P, Muller P, Wijmenga C, Klomp LWJ (2007) Molecular pathogenesis of Wilson and Menkes disease: correlation of mutations with molecular defects and disease phenotypes. J Med Genet 44:673–688PubMedCentralPubMedCrossRefGoogle Scholar
European Association for the Study of the Liver (2012) EASL clinical practice guidelines: Wilson’s disease. J Hepatol 56:671–685Google Scholar
Ferenci P, Caca K, Loudianos G et al (2003) Diagnosis and phenotypic classification of Wilson disease. Liver Int 23:139–142PubMedCrossRefGoogle Scholar
Huppke P, Brendel C, Kalscheuer V et al (2012) Mutations in SLC33A1 cause a lethal autosomal-recessive disorder with congenital cataracts, hearing loss, and low serum copper and ceruloplasmin. Am J Hum Genet 90:61–68PubMedCentralPubMedCrossRefGoogle Scholar
Kaler SG (1998) Diagnosis and therapy of Menkes syndrome, a genetic form of copper deficiency. Am J Clin Nutr 67S:1029S–1034SGoogle Scholar
Kennerson ML, Nicholson GA, Kaler SG et al (2010) Missense mutations in the copper transporter gene ATP7A cause X-linked distal hereditary motor neuropathy. Am J Hum Genet 86:343–352PubMedCentralPubMedCrossRefGoogle Scholar
Kim BE, Smith K, Petris MJ (2003) A copper treatable Menkes disease mutation associated with defective trafficking of a functional Menkes copper ATPase. J Med Genet 40:290–295PubMedCentralPubMedCrossRefGoogle Scholar
Martinelli D, Travaglini L, Drouin CA et al (2013) MEDNIK syndrome: a novel defect of copper metabolism treatable by zinc acetate therapy. Brain 136:872–881PubMedCrossRefGoogle Scholar
Moeller LB, Tuemer Z, Lund C et al (2000) Similar splice site mutations of the ATP7A gene lead to different phenotypes: classical Menkes disease or occipital horn syndrome. Am J Hum Genet 66:1211–1220CrossRefGoogle Scholar
Nicastro E, Ranucci G, Vajro P, Vegnente A, Iorio R (2010) Re-evaluation of the diagnostic criteria for Wilson disease in children with mild liver disease. Hepatology 52:1948–1956PubMedCrossRefGoogle Scholar
Tsukahara M, Imaizumi K, Kawai S, Kajii T (1994) Occipital Horn syndrome: report of a patient and review of the literature. Clin Genet 45:32–35PubMedCrossRefGoogle Scholar
Wiggelinkhuizen M, Tilanus MEC, Bollen CW, Houwen RHJ (2009) Systematic review: clinical efficacy of chelator agents and zinc in the initial treatment of Wilson disease. Aliment Pharmacol Ther 29:947–958PubMedCrossRefGoogle Scholar